Enhanced Skin Permeation of Hydrocortisone Using Nanoemulsion as Potential Vehicle

被引:19
作者
Altamimi, Mohammad [1 ]
Haq, Nazrul [1 ]
Alshehri, Sultan [1 ]
Qamar, Wajhul [2 ,3 ]
Shakeel, Faiyaz [1 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut, POB 2457, Riyadh 11451, Saudi Arabia
[2] King Saud Univ, Coll Pharm, Cent Lab, POB 2457, Riyadh 11451, Saudi Arabia
[3] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, POB 2457, Riyadh 11451, Saudi Arabia
关键词
Hydrocortisone; Nanoemulsion; Skin permeation; Solubility parameters; Transdermal delivery; TRANSDERMAL DRUG-DELIVERY; TRITON X100; BIOAVAILABILITY; SOLUBILITY; ABSORPTION; EFFICIENCY; STABILITY; EFFICACY; SYSTEM; SAFETY;
D O I
10.1002/slct.201902007
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The current work was performed to estimate the solubility and Hansen solubility parameters of a poorly soluble corticosteroid hydrocortisone (HCN) in various components of nanoemulsion and to enhance the skin permeation rate of HCN using nanoemulsions as potential vehicles. Screening studies suggested the use of Capryol-90 (oil), Triton-X100 (surfactant) and Transcutol-HP (cosurfactant) in the preparation of HCN nanoemulsions. HCN nanoemulsions were developed using low energy emulsification technique and characterized for droplet size, plolydispersity index (PDI), zeta potential (ZP), refractive index (RI), percent of transmittance (% T) and transmission electron microscopy (TEM) and evaluated for drug release behavior. Selected nanoemulsions and control (HCN suspension) were subjected to in vitro skin permeation studies. Optimized formula HSN8 showed droplet size of 52.6 nm, PDI of 0.109, ZP of -33.72 mV, RI of 1.337 and % T of 97.68%. TEM confirmed spherical-shaped droplets in nanometer range. In vitro drug release evaluation suggested significant release of HCN from optimized nanoemulsion (98.52%) compared with control (35.85%). Skin permeation profile of HCN from optimized nanoemulsion was also significant compared with control. These results suggested the potential of nanoemulsion in enhancing the transdermal delivery of HCN via rat skin.
引用
收藏
页码:10084 / 10091
页数:8
相关论文
共 38 条
[31]   Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: an overview [J].
Shakeel, Faiyaz ;
Shafiq, Sheikh ;
Haq, Nazrul ;
Alanazi, Fars K. ;
Alsarra, Ibrahim A. .
EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (08) :953-974
[32]   Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions [J].
Shakeel, Faiyaz ;
Ramadan, Wafa .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 75 (01) :356-362
[33]   Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies [J].
Shakeel, Faiyaz ;
Ramadan, Wafa ;
Ahmed, Musa A. .
JOURNAL OF DRUG TARGETING, 2009, 17 (06) :435-441
[34]   In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis [J].
Siddique, Muhammad Irfan ;
Katas, Haliza ;
Amin, Mohd Cairul Iqbal Mohd ;
Ng, Shiow-Fern ;
Zulfakar, Mohd Hanif ;
Jamil, Adawiyah .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 507 (1-2) :72-82
[35]   A review of the nonclinical safety of Transcutol®, a highly purified form of diethylene glycol monoethyl ether (DEGEE) used as a pharmaceutical excipient [J].
Sullivan, Dexter W., Jr. ;
Gad, Shayne C. ;
Julien, Marjorie .
FOOD AND CHEMICAL TOXICOLOGY, 2014, 72 :40-50
[36]   Nanoemulsions: increasing possibilities in drug delivery [J].
Sutradhar, Kumar Bishwajit ;
Amin, Md. Lutful .
EUROPEAN JOURNAL OF NANOMEDICINE, 2013, 5 (02) :97-110
[37]   Active secretion and enterocytic drug metabolism barriers to drug absorption (Reprinted from Advanced Drug Delivery Reviews, vol 25, pg 3-14, 1997) [J].
Wacher, VJ ;
Salphati, L ;
Benet, LZ .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :89-102
[38]   Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system [J].
Wu, CY ;
Benet, LZ .
PHARMACEUTICAL RESEARCH, 2005, 22 (01) :11-23